WALTHAM, Mass. — A new series of mini centrifuges provide researchers simplicity, ergonomics and flexibility in a compact footprint for personalized workstations. The Thermo Scientific mySPIN mini centrifuges are designed for protocols requiring quick spin downs, micro-filter cell separations and HPLC samples as well as applications with a higher RCF requirement. “Today’s researchers require fast […]

CARLSBAD, Calif. — Thermo Fisher Scientific today announced it has signed an agreement with Cynvenio Biosystems Inc., a molecular testing company focused on the genomic analysis of tumor biomarkers in the bloodstream, for rights to distribute its LiquidBiopsy platform. The addition of Cynvenio’s rare cell enrichment technology complements Thermo Fisher’s Ion Torrent Personal Genome Machine […]

CARLSBAD, Calif. — The newly released CE-IVD Oncomine Solid Tumor DNA kit from Thermo Fisher Scientific enables highly accurate and reliable multiplexed sequencing of formalin-fixed, paraffin embedded (FFPE) tumor samples with the quality and performance needed for the clinical laboratory. Compared to other molecular diagnostic testing methods, such as qPCR or Sanger sequencing, next-generation sequencing […]

CARLSBAD, Calif. — Today Thermo Fisher Scientific announced that it has released a next-generation sequencing (NGS) RNA panel and workflow that enables targeted sequencing of fusion transcripts for clinical research. The new Ion Torrent AmpliSeq RNA Fusion Lung Cancer Research Panel allows simultaneous sequencing of 70 ALK, RET, ROS1, and NTRK1 fusion transcripts associated with […]

BOTHELL, WA —- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues (“BioLife” or the “Company”), today announced preliminary revenue for the fourth quarter and full year 2014 and a recap of operational accomplishments. […]

HILDEN, Germany and BEVERLY, Massachusetts -– QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Prime Standard QIA) today announced the acquisition of the Enzyme Solutions Unit of Enzymatics, a world leader in the development, manufacturing, and OEM supply of enzymes essential to driving the adoption of Next-Generation Sequencing (NGS) and other genetic analysis technologies in life sciences research […]

Austin, TX — The NEXTflex™ 18S ITS Amplicon-Seq Kit simplifies the preparation of multiplexed amplicon libraries spanning the ITS1 and ITS2 hypervariable regions of eukaryotic 18S ribosomal RNA (rRNA) genes to permit the fast and cost-effective characterization of uncultured fungal and micro-eukaryotic organisms. Up to 384 multiplexing barcodes are available with this kit, to greatly […]

HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, has acquired all of the operations of HEKA Elektronik, or HEKA, a privately held biomedical instrumentation and software business with headquarters in Germany, for a total of approximately $6 […]

SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced the addition of an important new feature to its Genomic DNA ScreenTape assay—the DNA Integrity Number, or DIN, for assessing the integrity of genomic DNA. The new feature is designed to ensure the quality of genomics experiments, especially next-generation sequencing (NGS). It builds on […]